Biondo Investment Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,105
| Closed | -$2.8M | – | 87 |
|
|
2023
Q3 | $2.8M | Buy |
27,105
+1,927
| +8% | +$199K | 0.53% | 43 |
|
|
2023
Q2 | $3.06M | Buy |
25,178
+478
| +2% | +$58.1K | 0.57% | 40 |
|
|
2023
Q1 | $3.79M | Buy |
24,700
+515
| +2% | +$79.1K | 0.77% | 40 |
|
|
2022
Q4 | $4.34M | Sell |
24,185
-134
| -0.6% | -$24.1K | 0.97% | 37 |
|
|
2022
Q3 | $2.88M | Buy |
24,319
+777
| +3% | +$91.9K | 0.66% | 41 |
|
|
2022
Q2 | $3.36M | Buy |
23,542
+330
| +1% | +$47.1K | 0.74% | 41 |
|
|
2022
Q1 | $4M | Sell |
23,212
-1,190
| -5% | -$205K | 0.7% | 41 |
|
|
2021
Q4 | $6.2M | Buy |
24,402
+47
| +0.2% | +$11.9K | 1.03% | 36 |
|
|
2021
Q3 | $9.37M | Buy |
24,355
+60
| +0.2% | +$23.1K | 1.61% | 20 |
|
|
2021
Q2 | $5.71M | Buy |
+24,295
| New | +$5.71M | 0.98% | 41 |
|